Leading EIS Fund Manager announces a “record-breaking” Q4 in 2019
Par Equity, Edinburgh-based EIS fund manager has achieved one exit and 11 major investments in the last months of 2019. The sale of Dukosi to American private equity group KCK marked its 18th exit from the EIS fund and increased the cash returned to investors to £51million. Par Equity Partner Andrew Noble stated that the reason for their recent investment activity demonstrates the firm’s “success in raising funding for companies with exciting technologies based in the north of the UK”.
In the past few months, several London EIS managers invested in Par’s exciting portfolio companies Current Health and Novosound. The former received £9m in funding to continue the development of its industry disruptive remote healthcare monitoring technology. Meanwhile, Novosound, which is behind the world’s only fully flexible ultrasound sensor, garnered £3.3m in new investment.
The sale of Par EIS portfolio company Dukosi, and the record-breaking increase of investments into the portfolio illustrate that commercializing British ideas is more and more attractive to investors, not just in the UK but globally, according to Andrew Noble. As an award-winning EIS Fund manager, Par Equity will continue eyeing more innovative and growth opportunities to remain ahead of the pack.
Please note, past performance is no indicator of future performance and may not be repeated. EIS investments are long term, high risk and you may lose all of your capital and any tax breaks received. EIS investments are not suitable for all investors. Investors should be experienced in investing in Venture Capital or preferably seek advice from a suitably qualified IFA or financial adviser.
To find out more, please contact the Kin Capital sales team on 0203 743 3100 or email at email@example.com.